Polyethylene Glycol Polyester Block Copolymers: Biocompatible Carriers for Nanoparticulate Drug Delivery - Harnessing Biomaterials in Nanomedicine: Preparation, Toxicity, and Applications - page 69

2. Gordon, E. M., Barrett, R. W., Dower, W. J., Fodor, S. P., and Gallop, M. A.
(1994). Applications of combinatorial technologies to drug discovery.
2. Combinatorial organic synthesis, library screening strategies, and
future directions. J Med Chem 37: 1385-1401.
3. Stockwell, B. R. (2004). Exploring biology with small organic molecules.
Nature 432: 846-854.
4. Lipinski, C. A., Lombardo, F., Dominy, B. W., and Feeney, P. J. (2001).
Experimental and computational approaches to estimate solubility
and permeability in drug discovery and development settings. Adv
Drug Deliv Rev 46: 3-26.
5. Pawar, R., Shikanov, A., Vaisman, B., and Domb, A. J. (2004). Intravenous
and regional paclitaxel formulations. Curr Med Chem 11: 397-402.
6. Nahar, M., et al . (2006). Functional polymeric nanoparticles: an efficient
and promising tool for active delivery of bioactives. Crit Rev Ther Drug
Carrier Syst 23: 259-318.
7. Yasugi, K., Nagasaki, Y., Kato, M., and Kataoka, K. (1999). Preparation
and characterization of polymer micelles from poly(ethylene glycol)-
poly(D,L-lactide) block copolymers as potential drug carrier. J Control
Release 62: 89-100.
8. Croy, S. R., and Kwon, G. S. (2006). Polymeric micelles for drug delivery.
Curr Pharm Des 12: 4669-4684.
9. Kataoka, K., Harada, A., and Nagasaki, Y. (2001). Block copolymer
micelles for drug delivery: design, characterization and biological
significance. Adv Drug Deliv Rev 47: 113-131.
10. Aliabadi, H. M., and Lavasanifar, A. (2006). Polymeric micelles for drug
delivery. Expert Opin Drug Deliv 3: 139-162.
11. Avgoustakis, K. (2004). Pegylated poly(lactide) and poly(lactide-
co-glycolide) nanoparticles: preparation, properties and possible
applications in drug delivery. Curr Drug Deliv 1: 321-333.
12. Yoo, H. S., and Park, T. G. (2001). Biodegradable polymeric micelles
composed of doxorubicin conjugated PLGA-PEG block copolymer. J
Control Release 70: 63-70.
13. Moghimi, S. M., Hunter, A. C., and Murray, J. C. (2001). Long-circulating
and target-specific nanoparticles: theory to practice. Pharmacol Rev
53: 283-318.
14. Harris, J. M., Martin, N. E., and Modi, M. (2001). Pegylation: a novel
process for modifying pharmacokinetics. Clin Pharmacokinet 40:
539-551.
15. He, X. H., Shaw, P. C., and Tam, S. C. (1999). Reducing the immunogenicity
and improving the in vivo activity of trichosanthin by site-directed
pegylation. Life Sci 65: 355-368.